HP1-mediated formation of alternative lengthening of telomeres-associated PML bodies requires HIRA but not ASF1a

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Jiang, Wei Qin ^a,b   Nguyen, Akira ^a,b,c   Cao, Ying ^a,b   Chang, Andy C M ^a,b   Reddel, Roger R ^a,b  

^a CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; HETEROCHROMATIN PROTEIN 1; NUCLEAR PROTEIN; PROTEIN ASF1A; PROTEIN ASF1B; PROTEIN HIRA; PROTEIN P21; PROTEIN P53; REGULATOR PROTEIN; UNCLASSIFIED DRUG; ASF1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; HETEROCHROMATIN SPECIFIC NONHISTONE CHROMOSOMAL PROTEIN HP 1; HETEROCHROMATIN-SPECIFIC NONHISTONE CHROMOSOMAL PROTEIN HP-1; HIRA PROTEIN, HUMAN; NONHISTONE PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CELL ELONGATION; CELL GROWTH; CELL NUCLEUS INCLUSION BODY; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TELOMERE; UPREGULATION; ACTIVE TRANSPORT; ANIMAL; CELL AGING; CELL NUCLEUS; GENE SILENCING; GENETICS; HELA CELL; METABOLISM; NUCLEOLUS; TELOMERE HOMEOSTASIS;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL AGING; CELL CYCLE PROTEINS; CELL NUCLEOLUS; CELL NUCLEUS; CHROMOSOMAL PROTEINS, NON-HISTONE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HISTONE CHAPERONES; HUMANS; TELOMERE HOMEOSTASIS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79951876706     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017036     Document Type: Article

References (69)

1. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR, (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14: 4240-4248.
2. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR, (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3: 1271-1274.
3. Henson JD, Neumann AA, Yeager TR, Reddel RR, (2002) Alternative lengthening of telomeres in mammalian cells. Oncogene 21: 598-610.
4. Cesare AJ, Reddel RR, (2010) Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet 11: 319-330.
5. Murnane JP, Sabatier L, Marder BA, Morgan WF, (1994) Telomere dynamics in an immortal human cell line. EMBO J 13: 4953-4962.
6. Dunham MA, Neumann AA, Fasching CL, Reddel RR, (2000) Telomere maintenance by recombination in human cells. Nat Genet 26: 447-450.
7. Fasching CL, Bower K, Reddel RR, (2005) Telomerase-independent telomere length maintenance in the absence of ALT-associated PML bodies. Cancer Res 65: 2722-2729.
8. Marciniak RA, Cavazos D, Montellano R, Chen Q, Guarente L, et al. (2005) A novel telomere structure in human alternative lengthening of telomeres cell line. Cancer Res 65: 2730-2737.
9. Brachner A, Sasgary S, Pirker C, Rodgarkia C, Mikula M, et al. (2006) Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT. Cancer Res 66: 3584-3592.
10. Cerone MA, Autexier C, Londono-Vallejo JA, Bacchetti S, (2005) A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT. Oncogene 24: 7893-7901.
11. Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, et al. (1999) Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res 59: 4175-4179.
12. Wu G, Jiang X, Lee WH, Chen PL, (2003) Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen breakage syndrome 1. Cancer Res 63: 2589-2595.
13. Jiang WQ, Zhong ZH, Henson JD, Reddel RR, (2007) Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Oncogene 26: 4635-4647.
14. Tarsounas M, Munoz P, Claas A, Smiraldo PG, Pittman DL, et al. (2004) Telomere maintenance requires the RAD51D recombination/repair protein. Cell 117: 337-347.
15. Yankiwski V, Marciniak RA, Guarente L, Neff NF, (2000) Nuclear structure in normal and Bloom syndrome cells. Proc Natl Acad Sci U S A 97: 5214-5219.
16. Stavropoulos DJ, Bradshaw PS, Li X, Pasic I, Truong K, et al. (2002) The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum Mol Genet 11: 3135-3144.
17. Johnson FB, Marciniak RA, McVey M, Stewart SA, Hahn WC, et al. (2001) The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase. EMBO J 20: 905-913.
18. Zhu XD, Kuster B, Mann M, Petrini JH, de Lange T, (2000) Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat Genet 25: 347-352.
19. Wu G, Lee WH, Chen PL, (2000) NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phrases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres. J Biol Chem 275: 30618-30622.
20. Zhu XD, Niedernhofer L, Kuster B, Mann M, Hoeijmakers JH, et al. (2003) ERCC1/XPF removes the 3′ overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol Cell 12: 1489-1498.
21. Nabetani A, Yokoyama O, Ishikawa F, (2004) Localization of hRad9, hHus1, hRad1 and hRad17, and caffeine-sensitive DNA replication at ALT (alternative lengthening of telomeres)-associated promyelocytic leukemia body. J Biol Chem 279: 25849-25857.
22. Fan Q, Zhang F, Barrett B, Ren K, Andreassen PR, (2009) A role for monoubiquitinated FANCD2 at telomeres in ALT cells. Nucleic Acids Res 37: 1740-1754.
23. Silverman J, Takai H, Buonomo SB, Eisenhaber F, de Lange T, (2004) Human Rif1, ortholog of a yeast telomeric protein, is regulated by ATM and 53BP1 and functions in the S-phase checkpoint. Genes Dev 18: 2108-2119.
24. Moran-Jones K, Wayman L, Kennedy DD, Reddel RR, Sara S, et al. (2005) hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere. Nucleic Acids Res 33: 486-496.
25. Jiang WQ, Zhong ZH, Henson JD, Neumann AA, Chang AC, et al. (2005) Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of MRE11/RAD50/NBS1 complex. Mol Cell Biol 25: 2708-2721.
26. Potts PR, Yu H, (2007) The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins. Nat Struct Mol Biol 14: 581-590.
27. Grobelny JV, Godwin AK, Broccoli D, (2000) ALT-associated PML bodies are present in viable cells and are enriched in cells in the G2/M phase of the cell cycle. J Cell Sci 113: 4577-4585.
28. Molenaar C, Wiesmeijer K, Verwoerd NP, Khazen S, Eils R, et al. (2003) Visualizing telomere dynamics in living mammalian cells using PNA probes. EMBO J 22: 6631-6641.
29. Perrem K, Colgin LM, Neumann AA, Yeager TR, Reddel RR, (2001) Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol Cell Biol 21: 3862-3875.
30. Zhong ZH, Jiang WQ, Cesare AJ, Neumann AA, Wadhwa R, et al. (2007) Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres. J Biol Chem 282: 29314-29322.
31. Jiang WQ, Zhong ZH, Nguyen A, Henson JD, Toouli CD, et al. (2009) Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins. J Cell Biol 185: 797-810.
32. Lamour V, Lecluse Y, Desmaze C, Spector M, Bodescot M, et al. (1995) A human homolog of the S. cerevisiae HIR1 and HIR2 transcriptional repressors cloned from the DiGeorge syndrome critical region. Hum Mol Genet 4: 791-799.
33. Munakata T, Adachi N, Yokoyama N, Kuzuhara T, Horikoshi M, (2000) A human homologue of yeast anti-silencing factor has histone chaperone activity. Genes Cells 5: 221-233.
34. Umehara T, Horikoshi M, (2003) Transcription initiation factor IID-interactive histone chaperone CIA-II implicated in mammalian spermatogenesis. J Biol Chem 278: 35660-35667.
35. Le S, Davis C, Konopka JB, Sternglanz R, (1997) Two new S-phase-specific genes from Saccharomyces cerevisiae. Yeast 13: 1029-1042.
36. Tyler JK, Adams CR, Chen SR, Kobayashi R, Kamakaka RT, et al. (1999) The RCAF complex mediates chromatin assembly during DNA replication and repair. Nature 402: 555-560.
37. Kaufman PD, Cohen JL, Osley MA, (1998) Hir proteins are required for position-dependent gene silencing in Saccharomyces cerevisiae in the absence of chromatin assembly factor I. Mol Cell Biol 18: 4793-4806.
38. Singer MS, Kahana A, Wolf AJ, Meisinger LL, Peterson SE, et al. (1998) Identification of high-copy disrupters of telomeric silencing in Saccharomyces cerevisiae. Genetics 150: 613-632.
39. Sharp JA, Fouts ET, Krawitz DC, Kaufman PD, (2001) Yeast histone deposition protein Asf1p requires HIR proteins and PCNA for heterochromatic silencing. Curr Biol 11: 463-473.
40. Krawitz DC, Kama T, Kaufman PD, (2002) Chromatin assembly factor I mutants defective for PCNA binding require Asf1/Hir proteins for silencing. Mol Cell Biol 22: 614-625.
41. Daganzo SM, Erzberger JP, Lam WM, Skordalakes E, Zhang R, et al. (2003) Structure and function of the conserved core of histone deposition protein Asf1. Curr Biol 13: 2148-2158.
42. Ray-Gallet D, Quivy JP, Scamps C, Martini EM, Lipinski M, et al. (2002) HIRA is critical for a nucleosome assembly pathway independent of DNA synthesis. Mol Cell 9: 1091-1100.
43. Tagami H, Ray-Gallet D, Almouzni G, Nakatani Y, (2004) Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell 116: 51-61.
44. Tang Y, Poustovoitov MV, Zhao K, Garfinkel M, Canutescu A, et al. (2006) Structure of a human ASF1a-HIRA complex and insights into specificity of histone chaperone complex assembly. Nat Struct Mol Biol 13: 921-929.
45. Zhang R, Poustovoitov MV, Ye X, Santos HA, Chen W, et al. (2005) Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell 8: 19-30.
46. Zhang R, Chen W, Adams PD, (2007) Molecular dissection of formation of senescent associated heterochromatin foci. Mol Cell Biol 27: 2343-2358.
47. Narita M, Nunez S, Heard E, Narita M, Lin AW, et al. (2003) Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703-716.
48. Ye X, Zerlanko B, Zhang R, Somaiah N, Lipinski M, et al. (2007) Definition of pRB- and p53-dependent and independent steps in HIRA/ASF1a-mediated formation of senecence-associated heterochromatin foci. Mol Cell Biol 27: 2452-2465.
49. Slatter T, Gifford-Garner J, Wiles A, Tan X, Chen YJ, et al. (2010) Pilocytic astrocytomas have telomere-associated promyelocytic leukemia bodies without alternatively lengthened telomeres. Am J Pathol 177: 2694-2700.
50. Homer C, Knight DA, Hananeia L, Sheard P, Risk J, et al. (2005) Y-box factor YB1 controls p53 apoptotic function. Oncogene 24: 8314-8325.
51. Rogan EM, Bryan TM, Hukku B, Maclean K, Chang AC, et al. (1995) Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol 15: 4745-4753.
52. Warneford SG, Witton LJ, Townsend ML, Rowe PB, Reddel RR, et al. (1992) Germ-line splicing mutation of the p53 gene in a cancer-prone family. Cell Growth Differ 3: 839-846.
53. Maclean K, Rogan EM, Whitaker NJ, Chang AC, Rowe PB, et al. (1994) In vitro transformation of Li-Fraumeni syndrome fibroblasts by SV40 large T antigen mutants. Oncogene 9: 719-725.
54. Mello JA, Sillje HH, Roche DM, Kirschner DB, Nigg EA, et al. (2002) Human Asf1 and CAF-1 interact and synergize in a repair-coupled nucleosome assembly pathway. EMBO Rep 3: 329-334.
55. Adams PD, (2007) Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene 397: 84-93.
56. Boisvert FM, van Koningsbruggen S, Navascues J, Lamond AI, (2007) The multifunctional nucleolus. Nat Rev Mol Cell Biol 8: 574-585.
57. Wong LH, Ren H, Williams E, McGhie J, Ahn S, et al. (2009) Histone H3.3 incorporation provides a unique and functionally essential telomeric chromatin in embryonic stem cells. Genome Res 19: 404-414.
58. Banumathy G, Somaiah N, Zhang R, Tang Y, Hoffmann J, et al. (2009) Human UBN1 is an ortholog of yeast Hpc2p and has an essential role in the HIRA/ASF1a chromatin-remodeling pathway in senescent cells. Mol Cell Biol 29: 758-770.
59. Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T, (2001) Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410: 116-120.
60. Garcia-Cao M, O'Sullivan R, Peters AH, Jenuwein T, Blasco MA, (2004) Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat Genet 36: 94-99.
61. Ye X, Zerlanko B, Kennedy A, Banumathy G, Zhang R, et al. (2007) Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells. Mol Cell 27: 183-196.
62. Zhang R, Adams PD, (2007) Heterochromatin and its relationship to cell senescence and cancer therapy. Cell Cycle 6: 784-789.
63. Harborth J, Elbashir SM, Bechert K, Tuschl T, Weber K, (2001) Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci 114: 4557-4565.
64. Sripathy SP, Stevens J, Schultz DC, (2006) The KAP1 corepressor functions to coordinate the assembly of de novo HP1-demarcated microenvironments of heterochromatin required for KRAB zinc finger protein-mediated transcriptional repression. Mol Cell Biol 26: 8623-8638.
65. Zhang R, Liu ST, Chen W, Bonner M, Pehrson J, et al. (2007) HP1 proteins are essential for a dynamic nuclear response that rescues the function of perturbed heterochromatin in primary human cells. Mol Cell Biol 27: 949-962.
66. Groth A, Ray-Gallet D, Quivy JP, Lukas J, Bartek J, et al. (2005) Human Asf1 regulates the flow of S phase histones during replicational stress. Mol Cell 17: 301-311.
67. Groth A, Corpet A, Cook AJ, Roche D, Bartek J, et al. (2007) Regulation of replication fork progression through histone supply and demand. Science 318: 1928-1931.
68. Henson JD, Hannay JA, McCarthy SW, Royds JA, Yeager TR, et al. (2005) A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res 11: 217-225.
69. Toouli CD, Huschtscha LI, Neumann AA, Noble JR, Colgin LM, et al. (2002) Comparison of human mammary epithelial cells immortalized by simian virus 40 T-Antigen or by the telomerase catalytic subunit. Oncogene 21: 128-139.